Johnson & Johnson has just received approval from the FDA for emergency use of their COVID-19 vaccine, making it the 3rd vaccine, and the first typical “viral vector” vaccine to treat COVID here in the United States. Johnson & Johnson joins Astrazeneca as a more traditional alternative to the Moderna and Pfizer mRNA vaccines approved for COVID. Traditional vaccines inject actual pieces of a virus, whether alive or dead, to elicit a response from our immune system, in order to create antibodies that will protect against future exposures. Unfortunately, this new option uses aborted fetal cell line PER.C6 cells created in 1985 from the retina of an 18 week old aborted human fetus in the development, production and testing of the vaccine. So, the Johnson & Johnson COVID-19 vaccine can/does contain actual fetal DNA fragments along with the weakened virus.
For reported efficacy data and more information on the Johnson & Johnson vaccine, we are providing the following links:
Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines – Charles Lozier Institute – Updated March 3, 2021
An Overview of the Johnson & Johnson COVID-19 Vaccine – verywell health March 03, 2021